99mTc-GSA

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug Name99mTc-GSA
Drug Alias Name亚锡半乳糖酰人血清白蛋白二亚乙基三胺五乙酸盐锝(99mTc)半乳糖酰人血清白蛋白二亚乙基三胺五乙酸注射液Asialoscinti
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionRadionuclide imaging enhancersAsialoglycoprotein receptor binders
TargetsAsialoglycoprotein receptor
Therapy Area/IndicationsContrast agentsDiagnostic agents
Global Approved IndicationsDiagnostic agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1992/08/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Shihong Drug Development Center
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Hospital Chinese Academy Of Medical SciencesNihon Medi-Physics Co LtdBeijing Shihong Drug Development Center +[4] 
Inactive CompaniesN/A
Active IndicationsContrast agentsDiagnostic agents
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A